Efficacy and Safety of Switching from Innovator Rituximab to Biosimilar CT-P10 Compared with Continued Treatment with CT-P10: Results of a 56-Week Open-Label Study in Patients with Rheumatoid Arthritis

Efficacy and Safety of Switching from Innovator Rituximab to Biosimilar CT-P10 Compared with... BioDrugs (2017) 31:369–377 DOI 10.1007/s40259-017-0233-6 OR IGINAL RESEARCH ARTIC L E Efficacy and Safety of Switching from Innovator Rituximab to Biosimilar CT-P10 Compared with Continued Treatment with CT-P10: Results of a 56-Week Open-Label Study in Patients with Rheumatoid Arthritis 1 2 3 4 • • • • Won Park Chang-Hee Suh Seung Cheol Shim Francisco Fidencio Cons Molina 5 6 7 • • • Slawomir Jeka Francisco G. Medina-Rodriguez Pawel Hrycaj 8 9 10 11 • • • • Piotr Wiland Eun Young Lee Pavel Shesternya Volodymyr Kovalenko 12 13 14 • • • Leysan Myasoutova Marina Stanislav Sebastiao Radominski 1 15 16 16 • • • • Mie Jin Lim Jung-Yoon Choe Sang Joon Lee Sung Young Lee 16 17 Sung Hwan Kim Dae Hyun Yoo Published online: 9 June 2017 The Author(s) 2017. This article is an open access publication Abstract the RCT and switched to CT-P10 during the OLE (‘switch Background CT-P10 is a biosimilar candidate of innovator group’). rituximab (RTX) that demonstrated a comparable clinical Methods Patients who completed the RCT were recruited. profile to RTX in a phase I randomized controlled trial Based on the Disease Activity Score using 28 joints (RCT) in rheumatoid http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png BioDrugs Springer Journals

Efficacy and Safety of Switching from Innovator Rituximab to Biosimilar CT-P10 Compared with Continued Treatment with CT-P10: Results of a 56-Week Open-Label Study in Patients with Rheumatoid Arthritis

Loading next page...
 
/lp/springer_journal/efficacy-and-safety-of-switching-from-innovator-rituximab-to-nB7Npa4YpK
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by The Author(s)
Subject
Biomedicine; Molecular Medicine; Antibodies; Cancer Research; Pharmacotherapy
ISSN
1173-8804
eISSN
1179-190X
D.O.I.
10.1007/s40259-017-0233-6
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial